Xtant Medical Holdings stock trades at EUR 0.26 with USD 40.8 million market cap

Published on 10/20/2026 at 14:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At EUR 0.26 on October 20, 2026, Xtant Medical Holdings stock is trading. Market value is USD 40.8 million ahead of November 10, 2026 results.

Operating and market markers

Xtant Medical reported USD 23.0 million in second-quarter 2026 revenue on August 11, 2026.
Short interest fell to 143,564 shares on September 30, 2026, from 268,742 shares on September 15, 2026.
Xtant Medical Holdings stock trades at EUR 0.26 at 1:59 p.m. CEST at Lang & Schwarz on October 20, 2026.

XTNT, US98420P3082, Illustration mit AI erstellt.

Xtant Medical Holdings (US98420P3082) was trading at EUR 0.26 at Lang & Schwarz on October 20, 2026 at 1:59 p.m. CEST. The latest operating report showed USD 23.0 million in second-quarter 2026 revenue, while the company is scheduled to report its next quarter on November 10, 2026.

Revenue reset shapes the picture

According to MarketWatch, Xtant Medical Holdings reported total revenue of USD 23.0 million for the quarter ended June 30, 2026, down from USD 35.4 million in the same quarter of 2025. Net loss was USD 9.4 million, compared with net income of USD 3.6 million a year earlier.

The same August 11, 2026 filing showed gross margin of 57.9 percent, down from 68.6 percent. Management attributed the pressure to discontinued license revenue, reduced production efficiency and excess inventory charges, while full-year 2026 revenue guidance was reduced to USD 99 million to USD 103 million from USD 101 million to USD 105 million.

Three dated signals for XTNT

The recent sequence is clear. On August 11, 2026, Xtant reported USD 23.0 million in quarterly revenue. On September 15, 2026, short interest stood at 268,742 shares. On September 30, 2026, it had fallen to 143,564 shares, according to Transcript Daily.

What date matters next?

MarketBeat lists November 10, 2026, before the market opens, as the estimated date for third-quarter results, with an 8:30 a.m. ET conference call. Its consensus calls for USD 25.48 million in revenue and adjusted earnings per share of minus USD 0.0250.

Small-cap valuation meets operating pressure

Xtant Medical Holdings had a market capitalization of USD 40.8 million as of October 19, 2026. The company is listed on NYSE American under ticker XTNT and develops regenerative biologics, spinal implants and related medical devices for orthopedic and neurological surgeons. The next report will test whether the revenue decline has stabilized after the guidance cut.

Xtant Medical Holdings was trading at EUR 0.26 at Lang & Schwarz on October 20, 2026 at 1:59 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Xtant Medical Holdings stock.